1. ScholarBank@NUS

Prasad,R N V

rp06222

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Prasad,R N V
(not current staff)
Variants
Prasad, R.N.V.
 
Main Affiliation
 
Faculty
 
Email
obgprasa@nus.edu.sg
 

Publications

Results 21-39 of 39 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
211979Postponement of preterm birth with salbutamolTambyRaja, R.L. ; Prasad, R.N.V. ; Ratnam, S.S. 
222004Pregnancy outcomes following pre- and post-implantation exposure of Sprague-Dawley rats to benzyl isothiocyanateAdebiyi, A.; Adaikan, P.G. ; Prasad, R.N.V. 
231994'Pregnancy tumour' of the nasal septumLim, I. ; Singh, K. ; Prasad, R.N.V. ; Chan, H.L. ; Lam, R.S.T.; Ratnam, S.S. 
24Jun-1989Preinduction cervical priming with PGE2 vaginal film in primigravidae - A randomised, double blind, placebo controlled studyPrasad, R.N.V. ; Adaikan, P.G. ; Arulkumaran, S.; Ratnam, S.S. 
252000Proerectile pharmacological effects of Tribulus terrestris extract on the rabbit corpus cavernosumAdaikan, P.G. ; Gauthaman, K.; Prasad, R.N.V. ; Ng, S.C. 
26Sep-1986Randomized comparison of different prostaglandin analogues and laminaria tent for preoperative cervical dilatationKrishna, U.; Gupta, A.N.; Ma, H.-K.; Manullova, I.; Hingorani, V.; Prasad, R.N.V. ; Bygdeman, M.; Herczeg, J.
271998Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical primingSingh, K. ; Fong, Y.F.; Prasad, R.N.V. ; Dong, F. 
281-Jan-1999Severe hyperthermia following use of vaginal misoprostol for pre- operative cervical primingFong, Y.F. ; Singh, K. ; Prasad, R.N.V. 
291999Severe hyperthermia following use of vaginal misoprostol for pre- operative cervical primingFong, Y.F.; Singh, K. ; Prasad, R.N.V. 
302003Sexual effects of puncturevine (Tribulus terrestris) extract (protodioscin): An evaluation using a rat modelGauthaman, K. ; Ganesan, A.P. ; Prasad, R.N.V. 
31Feb-1996Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg or 1.0 mg vaginal gemeprostPrasad, R.N.V. ; Choolani, M.
321996Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg or 1.0 mg vaginal gemeprostPrasad, R.N.V. ; Choolani, M.
33Oct-1977Termination of early pregnancy (menstrual induction) with 16-phenoxy-ω-tetranor PGE2 methylsulfonylamideKarim, S.M.M.; Rao, B.; Ratnam, S.S. ; Prasad, R.N.V. ; Wong, Y.M.; Ilancheran, A.
341995The feasibility of early second trimester pregnancy (12 to 14 weeks) termination with single intra-amniotic injection of 15-methyl PGF2αPrasad, R.N.V. ; Adaikan, P.G. ; Anandakumar, C. ; Ratnum, S.S. 
352003Tocolytic and toxic activity of papaya seed extract on isolated rat uterusAdebiyi, A.; Adaikan, P.G. ; Prasad, R.N.V. 
361992Uterine rupture after induction of labour for intrauterine death using the prostaglandin E2 analogue sulprostonePrasad, R.N.V. ; Ratnam, S.S. 
371999Vaginal misoprostol for pre-abortion cervical priming: Is there an optimal evacuation time interval?Singh, K. ; Fong, Y.F.; Prasad, R.N.V. ; Dong, F.
381999Vaginal misoprostol for pre-abortion cervical priming: Is there an optimal evacuation time interval?Singh, K. ; Fong, Y.F.; Prasad, R.N.V. ; Dong, F.
391-Sep-2003WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: EfficacyVon Hertzen, H.; Honkanen, H.; Piaggio, G.; Bartfai, G.; Erdenetungalag, R.; Gemzell-Danielsson, K.; Gopalan, S.; Horga, M.; Jerve, F.; Mittal, S.; Ngoc, N.T.N.; Peregoudov, A.; Prasad, R.N.V. ; Pretnar-Darovec, A.; Shah, R.S.; Song, S.; Tang, O.S.; Wu, S.C.